Bessemer Group Inc. Grows Stake in Enovix Corporation $ENVX

Bessemer Group Inc. lifted its stake in shares of Enovix Corporation (NASDAQ:ENVXFree Report) by 400.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,534 shares of the company’s stock after purchasing an additional 10,030 shares during the period. Bessemer Group Inc.’s holdings in Enovix were worth $130,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also made changes to their positions in the company. Electron Capital Partners LLC raised its holdings in shares of Enovix by 18.6% during the first quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company’s stock valued at $49,272,000 after acquiring an additional 1,054,029 shares during the last quarter. Driehaus Capital Management LLC lifted its holdings in Enovix by 1.8% in the 1st quarter. Driehaus Capital Management LLC now owns 2,323,612 shares of the company’s stock valued at $17,055,000 after purchasing an additional 41,559 shares in the last quarter. Fred Alger Management LLC lifted its holdings in Enovix by 21.5% in the 1st quarter. Fred Alger Management LLC now owns 2,233,446 shares of the company’s stock valued at $16,393,000 after purchasing an additional 394,532 shares in the last quarter. CenterBook Partners LP lifted its holdings in Enovix by 71.0% in the 1st quarter. CenterBook Partners LP now owns 1,736,570 shares of the company’s stock valued at $12,746,000 after purchasing an additional 721,309 shares in the last quarter. Finally, Kingstone Capital Partners Texas LLC purchased a new position in Enovix in the 2nd quarter valued at $13,206,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Analyst Upgrades and Downgrades

ENVX has been the topic of a number of research reports. Wall Street Zen lowered Enovix from a “hold” rating to a “sell” rating in a report on Saturday, September 6th. Craig Hallum reiterated a “buy” rating and issued a $15.00 price objective (up previously from $12.00) on shares of Enovix in a report on Tuesday, July 8th. Benchmark increased their price objective on shares of Enovix from $15.00 to $25.00 and gave the company a “buy” rating in a report on Friday, July 25th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $12.00 price target (up from $9.00) on shares of Enovix in a research report on Thursday, July 24th. Finally, B. Riley reiterated a “buy” rating and set a $17.00 price objective (up previously from $12.00) on shares of Enovix in a research report on Thursday, July 10th. Five equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.88.

Check Out Our Latest Stock Report on Enovix

Enovix Price Performance

Shares of ENVX stock opened at $11.11 on Wednesday. The company has a debt-to-equity ratio of 0.82, a current ratio of 4.37 and a quick ratio of 4.11. The firm’s 50-day moving average is $10.80 and its two-hundred day moving average is $10.17. Enovix Corporation has a 12 month low of $5.27 and a 12 month high of $16.49. The company has a market capitalization of $2.18 billion, a PE ratio of -13.23 and a beta of 2.09.

Enovix (NASDAQ:ENVXGet Free Report) last released its quarterly earnings data on Tuesday, September 9th. The company reported ($0.13) EPS for the quarter. Enovix had a negative net margin of 481.35% and a negative return on equity of 73.88%. The business had revenue of $7.47 million during the quarter. Analysts predict that Enovix Corporation will post -1.01 earnings per share for the current year.

Insider Buying and Selling

In other news, COO Ajay Marathe sold 120,000 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $12.01, for a total transaction of $1,441,200.00. Following the completion of the transaction, the chief operating officer directly owned 1,027,259 shares in the company, valued at approximately $12,337,380.59. This represents a 10.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 14.10% of the company’s stock.

About Enovix

(Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Corporation (NASDAQ:ENVXFree Report).

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.